dihydroethidium has been researched along with dabigatran in 1 studies
| Studies (dihydroethidium) | Trials (dihydroethidium) | Recent Studies (post-2010) (dihydroethidium) | Studies (dabigatran) | Trials (dabigatran) | Recent Studies (post-2010) (dabigatran) |
|---|---|---|---|---|---|
| 308 | 3 | 99 | 3,887 | 261 | 3,490 |
| Protein | Taxonomy | dihydroethidium (IC50) | dabigatran (IC50) |
|---|---|---|---|
| Solute carrier family 22 member 2 | Homo sapiens (human) | 4.7 | |
| Prothrombin | Homo sapiens (human) | 0.0046 | |
| Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 8.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumhäkel, M; Böhm, M; Kratz, MT; Lee, IO; Schirmer, SH | 1 |
1 other study(ies) available for dihydroethidium and dabigatran
| Article | Year |
|---|---|
The effects of direct thrombin inhibition with dabigatran on plaque formation and endothelial function in apolipoprotein E-deficient mice.
Topics: Animals; Antithrombins; Apolipoproteins E; Benzimidazoles; beta-Alanine; Blood Pressure; Body Weight; Collagen; Dabigatran; Endothelium, Vascular; Ethidium; Fluorescent Dyes; Heart Rate; Male; Mice; Mice, Knockout; Microscopy, Fluorescence; Oxidative Stress; Plaque, Atherosclerotic; Thrombin | 2012 |